Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based …

TT Horlocker, E Vandermeuelen, SL Kopp… - Obstetric Anesthesia …, 2019 - journals.lww.com
The American Society of Regional Anesthesia and Pain Medicine (ASRA) convened its
Fourth Consensus Conference on Regional Anesthesia and Anticoagulation in conjunction …

2021 ELSO adult and pediatric anticoagulation guidelines

ABV McMichael, LM Ryerson, D Ratano, E Fan… - ASAIO …, 2022 - journals.lww.com
Disclaimer: These guidelines for adult and pediatric anticoagulation for extracorporeal
membrane oxygenation are intended for educational use to build the knowledge of …

Laboratory Testing in the era of Direct or non–vitamin K antagonist oral anticoagulants: a practical guide to measuring their activity and avoiding diagnostic errors

EJ Favaloro, G Lippi - Seminars in thrombosis and hemostasis, 2015 - thieme-connect.com
A new generation of antithrombotic agents has recently emerged. These provide direct
inhibition of either thrombin (factor IIa [FIIa]) or FXa, and are increasingly replacing the …

Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016

SA Kozek-Langenecker, AB Ahmed… - European Journal of …, 2017 - journals.lww.com
The management of perioperative bleeding involves multiple assessments and strategies to
ensure appropriate patient care. Initially, it is important to identify those patients with an …

Laboratory measurement of the direct oral anticoagulants

BJ Dale, NC Chan… - British journal of …, 2016 - Wiley Online Library
Direct oral anticoagulants (DOAC s), including the direct thrombin inhibitor, dabigatran, and
the direct factor Xa (FX a) inhibitors, rivaroxaban, apixaban and edoxaban, are approved for …

Laboratory assessment of direct oral anticoagulants

J Douxfils, RC Gosselin - Seminars in thrombosis and …, 2017 - thieme-connect.com
Oral vitamin K anticoagulation (warfarin, Coumadin, coumarin) has long been used for long-
term treatment and prophylaxis in a variety of clinical settings. Given the unpredictable …

Is it time to switch to bivalirudin for ECMO anticoagulation?

A Navaei, V Kostousov, J Teruya - Frontiers in Medicine, 2023 - frontiersin.org
For decades, unfractionated heparin (hereafter, heparin) has been the primary anticoagulant
used for extracorporeal membrane oxygenation (ECMO) support. More recently, however …

Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation

YMC Henskens, AJW Gulpen, R van Oerle… - Thrombosis journal, 2018 - Springer
Background Traditional coagulation tests are included in emergency guidelines for
management of patients on direct oral anticoagulants (DOACs) who experience acute …

Monitoring bivalirudin therapy in children on extracorporeal circulatory support devices: Thromboelastometry versus routine coagulation testing

J Teruya, L Hensch, K Bruzdoski, I Adachi, SKR Hui… - Thrombosis …, 2020 - Elsevier
Introduction Bivalirudin is an alternative to heparin anticoagulation in infants and children in
the setting of extracorporeal life support (ECLS). While activated partial thromboplastin time …

[HTML][HTML] Effect of standardized perioperative dabigatran interruption on the residual anticoagulation effect at the time of surgery or procedure

JD Douketis, G Wang, N Chan, JW Eikelboom… - Journal of Thrombosis …, 2016 - Elsevier
Essentials• Anticoagulants need to be stopped preprocedure so there is little or no
remaining anticoagulant effect.• We assessed the residual anticoagulant effect with …